STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Linde SVP files Form 3 with RSUs, options and 401k holdings

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Linde plc (LIN) reported an initial statement of beneficial ownership (Form 3) for its SVP, Americas, effective 10/22/2025. The officer holds 12,335.266 ordinary shares directly and 923.986 ordinary shares indirectly via a 401(k).

Reported derivative holdings include Restricted Stock Units for 1,064, 980, and 960 ordinary shares that vest and pay out on or about March 7, 2028, March 7, 2027, and March 7, 2026, respectively, on a one-for-one basis. Stock options are listed across multiple grants, including 7,468 options at an exercise price of $468.77 expiring 03/07/2035, and 6,340 options at $465.29 expiring 03/07/2034, each vesting in three equal annual installments beginning the March following grant. The filing also notes 240.682 deferred stock units payable one-for-one in ordinary shares under the company’s deferral plan.

The form was signed by Anthony M. Pepper as attorney-in-fact.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Glazer Benjamin

(Last) (First) (Middle)
C/O LINDE PLC
FORGE, 43 CHURCH STREET WEST

(Street)
WOKING SURREY X0 GU216HT

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/22/2025
3. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Americas
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 12,335.266 D
Ordinary Shares 923.986 I 401k
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) (1) Ordinary Shares 1,064 $0 D
Restricted Stock Units (2) (2) Ordinary Shares 980 $0 D
Restricted Stock Units (3) (3) Ordinary Shares 960 $0 D
Stock Options (right to buy) (4) 03/07/2035 Ordinary Shares 7,468 $468.77 D
Stock Options (right to buy) (5) 03/07/2034 Ordinary Shares 6,340 $465.29 D
Stock Options (right to buy) (6) 03/07/2033 Ordinary Shares 6,325 $354.14 D
Stock Options (right to buy) (7) 03/07/2032 Ordinary Shares 7,325 $270.99 D
Stock Options (right to buy) (8) 03/08/2031 Ordinary Shares 6,390 $253.68 D
Stock Options (right to buy) (9) 03/09/2030 Ordinary Shares 8,740 $173.13 D
Stock Options (right to buy) (10) 03/20/2029 Ordinary Shares 9,745 $176.13 D
Stock Options (right to buy) (11) 03/07/2028 Ordinary Shares 17,785 $154 D
Deferred Stock Units (12) (12) Ordinary Shares 240.682 (13) D
Explanation of Responses:
1. Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
2. Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
3. Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
4. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
5. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
6. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
7. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
8. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
9. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
10. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
11. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.
12. Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
13. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
Remarks:
Anthony M. Pepper as attorney-in-fact 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Linde (LIN) report in this Form 3?

An initial statement of beneficial ownership for its SVP, Americas, effective 10/22/2025.

How many Linde (LIN) ordinary shares does the officer hold directly and indirectly?

Direct: 12,335.266 shares; Indirect via 401(k): 923.986 shares.

What RSUs are reported in the Linde (LIN) Form 3?

RSUs for 1,064, 980, and 960 shares, vesting on or about Mar 7, 2028, Mar 7, 2027, and Mar 7, 2026, one-for-one.

What stock options are disclosed, with prices and expirations?

Examples: 7,468 options at $468.77 expiring 03/07/2035; 6,340 at $465.29 expiring 03/07/2034; each vests in three annual installments.

Are there deferred stock units in this filing?

Yes, 240.682 deferred stock units, payable one-for-one in ordinary shares under the company’s plan.

Who signed the Linde (LIN) Form 3?

Signed by Anthony M. Pepper as attorney-in-fact.

What is the officer’s role at Linde (LIN)?

SVP, Americas.
Linde Plc

NASDAQ:LIN

LIN Rankings

LIN Latest News

LIN Latest SEC Filings

LIN Stock Data

183.36B
465.67M
0.26%
87.42%
1.13%
Specialty Chemicals
Industrial Inorganic Chemicals
Link
United Kingdom
WOKING SURREY